N4 Pharma (LON:N4P) Stock Price Up 27.2% – What’s Next?

Shares of N4 Pharma Plc (LON:N4P) rose 27.2% on Wednesday . The stock traded as high as GBX 0.75 ($0.01) and last traded at GBX 0.67 ($0.01). Approximately 9,267,938 shares changed hands during mid-day trading, an increase of 322% from the average daily volume of 2,194,081 shares. The stock had previously closed at GBX 0.53 ($0.01).

N4 Pharma Stock Performance

The firm has a market capitalization of £2.76 million, a PE ratio of -55.00 and a beta of -0.37. The company has a debt-to-equity ratio of 1.62, a quick ratio of 7.28 and a current ratio of 22.73. The business’s fifty day simple moving average is GBX 0.62 and its 200-day simple moving average is GBX 0.57.

N4 Pharma Company Profile

N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd

N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.